{"addison's disease": 42.23, "adrenal insufficiency": 31.95, "adrenocortical insufficiency acute": 14.6, "adrenocorticotropic hormone deficiency": 59.1, "amylase increased": 2.47, "aplasia pure red cell": 2.84, "aplastic anaemia": 2.98, "arthritis": 5.73, "atrioventricular block complete": 2.49, "autoimmune colitis": 330.45, "autoimmune haemolytic anaemia": 15.49, "autoimmune hepatitis": 54.05, "autoimmune nephritis": 187.44, "autoimmune pancreatitis": 59.76, "autoimmune thyroiditis": 23.05, "capillary leak syndrome": 10.13, "cardiogenic shock": 2.58, "chronic gastritis": 7.63, "clostridium difficile infection": 2.66, "colitis": 82.25, "cortisol decreased": 9.95, "cutaneous vasculitis": 3.4, "cytokine release syndrome": 2.66, "dermatitis": 5.92, "diabetes mellitus": 3.0, "diabetic ketoacidosis": 7.0, "diarrhoea": 2.12, "diarrhoea haemorrhagic": 2.25, "drug reaction with eosinophilia and systemic symptoms": 2.19, "drug-induced liver injury": 2.95, "duodenitis": 20.07, "encephalitis": 9.9, "encephalitis autoimmune": 22.59, "endocrine disorder": 29.41, "enteritis": 14.94, "enterocolitis": 14.42, "fulmit type 1 diabetes mellitus": 41.26, "gastritis": 3.28, "general physical health deterioration": 2.29, "giant cell arteritis": 7.66, "glucocorticoid deficiency": 101.68, "guillain-barre syndrome": 6.2, "haemophagocytic lymphohistiocytosis": 12.98, "hepatic cytolysis": 2.72, "hepatitis": 30.16, "hepatotoxicity": 23.06, "hypercalcaemia": 2.35, "hyperthyroidism": 16.08, "hypertransaminasaemia": 14.6, "hypophysitis": 503.18, "hypopituitarism": 83.29, "hypothalamo-pituitary disorder": 14.01, "hypothyroidism": 15.8, "immune thrombocytopenia": 5.87, "immune-mediated adrenal insufficiency": 37.27, "immune-mediated adverse reaction": 36.06, "immune-mediated arthritis": 72.69, "immune-mediated dermatitis": 93.67, "immune-mediated encephalitis": 277.53, "immune-mediated enterocolitis": 294.36, "immune-mediated gastritis": 128.94, "immune-mediated hepatic disorder": 31.8, "immune-mediated hepatitis": 356.17, "immune-mediated hyperthyroidism": 52.44, "immune-mediated hypophysitis": 788.39, "immune-mediated hypothyroidism": 45.23, "immune-mediated lung disease": 109.52, "immune-mediated myasthenia gravis": 97.42, "immune-mediated myocarditis": 199.96, "immune-mediated myositis": 94.93, "immune-mediated nephritis": 254.1, "immune-mediated neuropathy": 149.89, "immune-mediated pancreatitis": 74.48, "immune-mediated thyroiditis": 321.58, "immune-mediated uveitis": 211.06, "infusion related reaction": 2.79, "intentional product use issue": 24.55, "intestinal perforation": 9.58, "iridocyclitis": 25.05, "kidney transplant rejection": 5.7, "large intestine perforation": 15.13, "lichenoid keratosis": 13.18, "lipase increased": 5.24, "lymphocytic hypophysitis": 512.18, "maligt neoplasm progression": 28.86, "meningitis": 3.77, "meningitis aseptic": 6.69, "metastases to central nervous system": 15.68, "metastases to liver": 3.01, "metastases to lung": 5.91, "metastases to lymph nodes": 3.59, "metastatic maligt melanoma": 16.33, "myasthenia gravis": 23.25, "myasthenic syndrome": 34.39, "myocarditis": 8.38, "myopathy": 3.99, "myositis": 23.04, "nephritis": 27.25, "nephropathy toxic": 2.13, "non-small cell lung cancer": 12.92, "off label use": 2.73, "optic neuritis": 6.01, "orbital myositis": 157.71, "pemphigoid": 6.67, "peritonitis": 2.22, "pneumonitis": 28.37, "polyarthritis": 9.54, "polymyalgia rheumatica": 4.9, "polyneuropathy": 5.62, "prescribed overdose": 4.09, "prescribed underdose": 4.81, "pulmonary toxicity": 3.85, "radiation necrosis": 107.59, "radiculopathy": 7.17, "rash maculo-papular": 2.68, "sarcoidosis": 13.08, "secondary adrenocortical insufficiency": 54.53, "sjogren's syndrome": 13.29, "skin toxicity": 20.66, "thyroid disorder": 3.98, "thyroiditis": 69.9, "toxic epidermal necrolysis": 4.65, "transaminases increased": 2.62, "tubulointerstitial nephritis": 12.22, "tumour pseudoprogression": 59.56, "type 1 diabetes mellitus": 38.57, "uveitis": 9.07, "vasculitis": 2.92, "vitiligo": 102.18, "vogt-koyanagi-harada disease": 36.58}